Integrated safety in tocilizumab clinical trials

INTRODUCTION: The efficacy and safety of tocilizumab in patients with rheumatoid arthritis have been evaluated in a comprehensive phase 3 program. Patients from these randomized trials could receive tocilizumab treatment in open-label extension trials. Here, the long-term safety profile of tocilizum...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiff, Michael H, Kremer, Joel M, Jahreis, Angelika, Vernon, Emma, Isaacs, John D, van Vollenhoven, Ronald F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308069/
https://www.ncbi.nlm.nih.gov/pubmed/21884601
http://dx.doi.org/10.1186/ar3455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308069/
https://www.ncbi.nlm.nih.gov/pubmed/21884601
http://dx.doi.org/10.1186/ar3455

Ejemplares similares